Keryx withdraws 2016 forecast on renal drug supply disruption
 

Keryx withdraws 2016 forecast on renal drug supply disruption
(Reuters) - Keryx Biopharmaceuticals Inc said it was withdrawing its full-year forecast due to issues related to the production of its only approved drug, Auryxia.http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...YU:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...YU:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/spwvwGv7vTE